Yohei Doi

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 9

Top Topics

Chronic Kidney Disease

Ejection Fraction

Placebo Controlled

Top Venues

Clinical and experimental nephrology

Diabetes, obesity & metabolism

Hypertension (Dallas, Tex. : 1979)

Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research

This page only lists publications with an associated author ORCID identifier.

Publications

Yohei Doi, Maki Shinzawa, Tetsuya Arisato, Hideaki Oka, Ayumi Matsumoto, Harumi Kitamura, Yumi Nakazono, Yoichi Nishiya, Yoshiyasu Ueda, Taro Kamimura, Terumasa Hayashi, Fumiki Yoshihara, Yoshitaka Isaka
Effects of sodium-glucose co-transporter 2 inhibitors on ultrafiltration in patients with peritoneal dialysis: a protocol for a randomized, double-blind, placebo-controlled, crossover trial (EMPOWERED). Clinical and experimental nephrology 28 (7) (2024)
Yohei Doi, Maki Shinzawa, Tetsuya Arisato, Hideaki Oka, Ayumi Matsumoto, Harumi Kitamura, Yumi Nakazono, Yoichi Nishiya, Yoshiyasu Ueda, Taro Kamimura, Terumasa Hayashi, Fumiki Yoshihara, Yoshitaka Isaka
Effects of sodium-glucose co-transporter 2 inhibitors on ultrafiltration in patients with peritoneal dialysis: a protocol for a randomized, double-blind, placebo-controlled, crossover trial (EMPOWERED). Clinical and experimental nephrology 28 (7) (2024)
Yohei Doi, Maki Shinzawa, Tetsuya Arisato, Hideaki Oka, Ayumi Matsumoto, Harumi Kitamura, Yumi Nakazono, Yoichi Nishiya, Yoshiyasu Ueda, Taro Kamimura, Terumasa Hayashi, Fumiki Yoshihara, Yoshitaka Isaka
Effects of sodium-glucose co-transporter 2 inhibitors on ultrafiltration in patients with peritoneal dialysis: a protocol for a randomized, double-blind, placebo-controlled, crossover trial (EMPOWERED). Clinical and experimental nephrology (2024)
Yohei Doi, Maki Shinzawa, Tetsuya Arisato, Hideaki Oka, Ayumi Matsumoto, Harumi Kitamura, Yumi Nakazono, Yoichi Nishiya, Yoshiyasu Ueda, Taro Kamimura, Terumasa Hayashi, Fumiki Yoshihara, Yoshitaka Isaka
Effects of sodium-glucose co-transporter 2 inhibitors on ultrafiltration in patients with peritoneal dialysis: a protocol for a randomized, double-blind, placebo-controlled, crossover trial (EMPOWERED). Clinical and experimental nephrology 28 (7) (2024)
Yohei Doi, Maki Shinzawa, Tetsuya Arisato, Hideaki Oka, Ayumi Matsumoto, Harumi Kitamura, Yumi Nakazono, Yoichi Nishiya, Yoshiyasu Ueda, Taro Kamimura, Terumasa Hayashi, Fumiki Yoshihara, Yoshitaka Isaka
Effects of sodium-glucose co-transporter 2 inhibitors on ultrafiltration in patients with peritoneal dialysis: a protocol for a randomized, double-blind, placebo-controlled, crossover trial (EMPOWERED). Clinical and experimental nephrology 28 (7) (2024)
Yohei Doi, Takayuki Hamano, Satoshi Yamaguchi, Yusuke Sakaguchi, Jun-Ya Kaimori, Yoshitaka Isaka
Mediators between canagliflozin and renoprotection vary depending on patient characteristics: Insights from the CREDENCE trial. Diabetes, obesity & metabolism (2023)
Tatsufumi Oka, Yusuke Sakaguchi, Koki Hattori, Yuta Asahina, Sachio Kajimoto, Yohei Doi, Jun-Ya Kaimori, Yoshitaka Isaka
Mineralocorticoid Receptor Antagonist Use and Hard Renal Outcomes in Real-World Patients With Chronic Kidney Disease. Hypertension (Dallas, Tex. : 1979) 79 (3) (2022)
Yohei Doi, Makoto Tsujita, Takayuki Hamano, Yoshitsugu Obi, Tomoko Namba-Hamano, Toshihide Tomosugi, Kenta Futamura, Manabu Okada, Takahisa Hiramitsu, Norihiko Goto, Akira Nishiyama, Asami Takeda, Shunji Narumi, Yoshihiko Watarai, Yoshitaka Isaka
The effect of cholecalciferol supplementation on allograft function in incident kidney transplant recipients: A randomized controlled study. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 21 (9) (2021)
Makoto Tsujita, Yohei Doi, Yoshitsugu Obi, Takayuki Hamano, Toshihide Tomosugi, Kenta Futamura, Manabu Okada, Takahisa Hiramitsu, Norihiko Goto, Yoshitaka Isaka, Asami Takeda, Shunji Narumi, Yoshihiko Watarai
Cholecalciferol Supplementation Attenuates Bone Loss in Incident Kidney Transplant Recipients: A Prespecified Secondary Endpoint Analysis of a Randomized Controlled Trial. Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research (2021)